Improving Variant Calling in Cancer Genomics with Better Reference Genomes
Author Information
Author(s): Shuming Guo, Zhuo Huang, Yanming Zhang, Yukun He, Xiangju Chen, Wenjuan Wang, Lansheng Li, Yu Kang, Zhancheng Gao, Jun Yu, Zhenglin Du, Yanan Chu
Primary Institution: Linfen Central Hospital, China National Center for Bioinformation, Beijing Institute of Genomics, Chinese Academy of Sciences
Hypothesis
Can population-specific reference genomes improve the accuracy of variant calling in whole-exome sequencing data for Chinese patients?
Conclusion
Using the T2T-YAO reference genome significantly enhances the accuracy of variant calling in whole-exome sequencing for Chinese patients compared to the GRCh38 reference.
Supporting Evidence
- T2T-YAO outperformed GRCh38 by obtaining 7.41% more mapped reads.
- Using T2T-YAO reduced the number of benign variant calls while maintaining sensitivity for pathogenic variants.
- The study highlights the need for population-specific reference genomes in genomic analysis.
Takeaway
This study shows that using a reference genome that matches the population can help doctors find genetic changes in cancer more accurately.
Methodology
The study compared the performance of three reference genomes (T2T-YAO, T2T-CHM13, and GRCh38) using whole-exome sequencing data from 19 tumor samples of Chinese patients.
Potential Biases
Potential bias due to the use of FFPE samples and the absence of normal samples for germline variant filtering.
Limitations
The study used a small sample size and FFPE samples, which may affect data quality and the statistical significance of the findings.
Participant Demographics
19 tumor samples from Han Chinese patients, including 9 benign and 10 malignant gastric tumors.
Statistical Information
P-Value
5.945 × 10−5
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website